Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria

被引：0

作者：

Francesca Remelli

Elisa Maietti

Pasquale Abete

Giuseppe Bellelli

Mario Bo

Antonio Cherubini

Francesco Corica

Mauro Di Bari

Marcello Maggio

Maria Rosaria Rizzo

Andrea P. Rossi

Francesco Landi

Stefano Volpato

机构：

[1] University of Ferrara,Department of Medical Science

[2] University of Naples Federico II,Department of Translational Medical Sciences

[3] University of Milano-Bicocca,School of Medicine and Surgery

[4] Milan,Section of Geriatrics, Department of Medical Sciences

[5] and Acute Geriatric Unit,Geriatria, Accettazione Geriatrica e Centro di Ricerca per l’Invecchiamento,

[6] San Gerardo Hospital,Department of Clinical and Experimental Medicine

[7] University of Turin,Department of Experimental and Clinical Medicine

[8] IRCCS-INRCA,Geriatric Intensive Care Unit, Department of Geriatrics and Medicine

[9] University of Messina,Department Medicine and Surgery, Geriatric Rehabilitation Department

[10] Research Unit of Medicine of Aging,Department of Advanced Medical and Surgical Sciences

[11] University of Florence,Department of Medicine, Geriatrics Division

[12] Azienda Ospedaliero-Universitaria Careggi,Department of Geriatrics, Neurosciences and Orthopaedics

[13] University of Parma,Center for Clinical Epidemiology, School of Medicine

[14] University of Campania Luigi Vanvitelli,Department of Biomedical and Neuromotor Sciences

[15] University of Verona,undefined

[16] Catholic University of the Sacred Heart,undefined

[17] University of Ferrara,undefined

[18] University of Bologna,undefined

来源：

Aging Clinical and Experimental Research | 2022年 / 34卷

关键词：

Sarcopenic obesity; Sarcopenia; Diabetes; Acute care; Mortality;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：113 / 120

页数：7

共 91 条

[1]

Batsis JA(2018)Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies Nat Rev Endocrinol 9 513-537

[2]

Villarel DT(2013)Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004 J Am Geriatr Soc 61 974-980

[3]

Batsis JA(2021)Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria Aging Clin Exp Res 33 247-252

[4]

Barre LK(1997)Sarcopenia: origins and clinical relevance J Nutr 127 990S-991S

[5]

Mackenzie TA(2020)Physical activity and sarcopenia in older adults Aging Clin Exp Res 32 1675-1687

[6]

Xie W(2009)IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D Osteoporos Int 20 1807-1820

[7]

Xiao G(2019)Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 48 16-31

[8]

Fan Y(2014)The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates J Gerontol Ser A Biol Sci Med Sci 69 547-558

[9]

Rosenberg IH(2020)Validation of population-based cut-offs for low muscle mass and strength Eur Geriatr Med 11 713-714

[10]

Meier NF(2010)Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS) Diabetes Care 33 1497-1499

← 1 2 3 4 5 6 7 8 9 10 →